Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats

Life Sciences

Volumn 90, Issue 5-6, 2012, Pages 228-235

  Lobato, N S ^a,b   Filgueira, F P ^a   Hagihara, G N ^a   Akamine, E H ^a   Pariz, J R ^a   Tostes, R C ^a   Carvalho, M H C ^a   Fortes, Z B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Goias   (Brazil)

Author keywords

Metformin; Monosodium glutamate; Obesity; Vascular dysfunction

Indexed keywords

ACETYLCHOLINE; GLIFAGE; GLUTAMATE SODIUM; INDOMETACIN; METFORMIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PROSTACYCLIN; PROSTANOID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; MALE; MESENTERIC ARTERY; METABOLIC PARAMETERS; NONHUMAN; OBESITY; PROTEIN SECRETION; RAT; VASCULAR DISEASE;

ACETYLCHOLINE; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; EPOPROSTENOL; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INDOMETHACIN; INSULIN; INSULIN RESISTANCE; MALE; MESENTERIC ARTERIES; METFORMIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; NOREPINEPHRINE; OBESITY; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SODIUM GLUTAMATE; THROMBOXANE A2;

RATTUS;

EID: 84856101462     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.11.005     Document Type: Article

References (35)

1. F. Abbasi, M. Carantoni, Y.I. Chen, and G.M. Reaven Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin Diabetes Care 21 1998 1301 1305 (Pubitemid 28365687)
2. F. Abbasi, T. McLaughlin, C. Lamendola, H. Yeni-Komshian, A. Tanaka, and T. Wang Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers J Clin Endocrinol Metab 84 1999 3903 3906 (Pubitemid 30644172)
3. E.H. Akamine, E.M. Kawamoto, C. Scavone, D. Nigro, M.H. Carvalho, and R.C. Tostes Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin J Vasc Res 43 4 2006 309 320 (Pubitemid 44167868)
4. C.J. Bailey Metformin: effects on micro and macrovascular complications in type 2 diabetes Cardiovasc Drugs Ther 22 3 2008 215 224
5. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
6. L.J. Dominguez, A.J. Davidoff, P.R. Srinivas, P.R. Standley, M.F. Walsh, and J.R. Sowers Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle Endocrinology 137 1 1996 113 121 (Pubitemid 26004981)
7. X. Du, D. Edelstein, S. Obici, N. Higham, M.H. Zou, and M. Brownlee Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation J Clin Invest 116 4 2006 1071 1080
8. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK prospective diabetes study (UKPDS) group Lancet 352 1998 854 865
9. M. Feletou, and P.M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (the Wiggers Award lecture) Am J Physiol Heart Circ Physiol 291 2006 H985 H1002
10. U. Förstermann, and T. Münzel MD Endothelial nitric oxide synthase in vascular disease Circulation 113 2006 1708 1714
11. A. Gallo, G. Ceolotto, P. Pinton, E. Iori, E. Murphy, and G.A. Rutter Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism Diabetes 54 2005 1123 1131 (Pubitemid 40446327)
12. C.J. Glueck, R.N. Fontaine, P. Wang, M.T. Subbiah, K. Weber, and E. Illig Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30 Metabolism 50 2001 856 861 (Pubitemid 32700469)
13. M.I. Goran, G.D. Ball, and M.L. Cruz Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents J Clin Endocrinol Metab 88 4 2003 1417 1427 (Pubitemid 36623349)
14. P.J. Grant Beneficial effects of metformin on haemostasis and vascular function in man Diabetes Metab 29 2003 6S44-6S52 (Pubitemid 37187090)
15. J.O. Hill Understanding and addressing the epidemic of obesity: an energy balance perspective Endocr Rev 27 2006 750 761 (Pubitemid 44936058)
16. E. Hopps, D. Noto, G. Caimi, and M.R. Averna A novel component of the metabolic syndrome: the oxidative stress Nutr Metab Cardiovasc Dis 20 1 2010 72 77
17. R.S. Hundal, M. Krssak, S. Dufour, D. Laurent, V. Lebon, and V. Chandramouli Mechanism by which metformin reduces glucose production in type 2 diabetes Diabetes 49 2000 2063 2069
18. M.A. Iñiguez, C. Cacheiro-Llaguno, N. Cuesta, M.D. Díaz-Muñoz, and M. Fresno Prostanoid function and cardiovascular disease Arch Physiol Biochem 114 3 2008 201 209 (Pubitemid 352009306)
19. K. Kuboki, Z.Y. Jiang, N. Takahara, S.W. Ha, M. Igarashi, and T. Yamauchi Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin Circulation 101 6 2000 676 681 (Pubitemid 30094740)
20. R. Kurukulasuriya, M.A. Banerji, R. Chaiken, and H. Lebovitz Selective decrease in visceral fat is associated with weight loss during metformin treatment in African Americans with type 2 diabetes Diabetes 48 suppl. 1999 A315
21. J.M. Lawrence, J. Reid, G.J. Taylor, C. Stirling, and J.P. Reckless Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes Diabetes Care 27 1 2004 41 46 (Pubitemid 38196707)
22. A. Lerman, and A.M. Zeiher Endothelial function: cardiac events Circulation 111 2005 363 368 (Pubitemid 40165345)
23. L. Lionetti, M.P. Mollica, A. Lombardia, G. Cavalierea, G. Gifunia, and A. Barletta From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation Nutr Metab Cardiovasc Dis 19 2 2009 146 152
24. N.S. Lobato, F.P. Filgueira, E.H. Akamine, A.P. Davel, L.V. Rossoni, and R.C. Tostes Obesity induced by neonatal treatment with monosodium glutamate impairs microvascular reactivity in adult rats: Role of NO and prostanoids Nutr Metab Cardiovasc Dis 21 10 2011 808 816
25. M. Mahrouf, N. Ouslimani, J. Peynet, R. Djelidi, M. Couturier, and P. Therond Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C Biochem Pharmacol 72 2006 176 183 (Pubitemid 43850435)
26. M. Matsuda Measuring and estimating insulin resistance in clinical and research settings Nutr Metab Cardiovasc Dis 20 2 2010 79 86
27. T. Matsumoto, E. Noguchi, K. Ishida, T. Kobayashi, N. Yamada, and K. Kamata Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes Am J Physiol Heart Circ Physiol 295 3 2008 H1165 H1176
28. D.M. Nathan, J.B. Buse, M.B. Davidson, R.J. Heine, R.R. Holman, and R. Sherwin Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy Diabetes Care 29 2006 1963 1972
29. G.A. Nichols, and A. Gomez-Caminero Weight changes following the initiation of new anti-hyperglycaemic therapies Diabetes Obes Metab 9 2007 96 102 (Pubitemid 44921047)
30. N. Ouslimani, J. Peynet, D. Bonnefont-Rousselot, P. Therond, A. Legrand, and J.L. Beaudeux Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells Metabolism 54 2005 829 834 (Pubitemid 40725333)
31. P.A. Stapleton, M.E. James, A.G. Goodwill, and J.C. Frisbee Obesity and vascular dysfunction Pathophysiology 15 2 2008 79 89
32. K. Tziomalos, V.G. Athyros, A. Karagiannis, and D.P. Mikhailidis Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management Nutr Metab Cardiovasc Dis 20 2 2010 140 146
33. N.F. Wiernsperger, and C.J. Bailey The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms Drugs 58 1 1999 31 39 (Pubitemid 129758579)
34. K. Yuhki, H. Kashiwagi, F. Kojima, J. Kawabe, and F. Ushikubi Roles of prostanoids in the pathogenesis of cardiovascular diseases Int Angiol 29 2 Suppl. 2010 19 27
35. K.C. Zalesin, B.A. Franklin, W.M. Miller, E.D. Peterson, and P.A. McCullough Impact of obesity on cardiovascular disease Endocrinol Metab Clin North Am 37 3 2008 663 684